Tag: Covid Vaccine

Covid Vax In Pregnancy Produces Persistent Antibodies In Infants: Study
Covid Vax In Pregnancy Produces Persistent Antibodies In Infants: Study

At six months, the researchers looked at 28 of the infants born to vaccinated mothers and found 57 per cent (16 of 28) still had detectable IgG. That was compared with just 8 per cent (1 of 12) born to infected mothers.

  • Tuesday, 08 February 2022
Single-Dose Sputnik Light COVID Vaccine Gets DCGI Nod
Single-Dose Sputnik Light COVID Vaccine Gets DCGI Nod

A Lancet study has also shown that a single jab of this vaccine is 78.6-83.7% efficient against COVID-19, which is significantly better than the other two-shot vaccines.

  • Sunday, 06 February 2022
Painless Vaccination
Inoculation Of Needle-Free Covid-19 Vaccine ‘ZyCov-D’ Begins At Patna

Inoculation Of Needle-Free Covid-19 Vaccine ‘ZyCov-D’ Begins At Patna

Video Icon
  • Saturday, 05 February 2022
Centre Places Purchase Order For 5 Cr Doses Of Corbevax Covid Vaccine Each Costing Rs 145 Sans Tax
Centre Places Purchase Order For 5 Cr Doses Of Corbevax Covid Vaccine Each Costing Rs 145 Sans Tax

India's Drug Regulator approved India's first indigenously developed RBD protein sub-unit vaccine against COVID-19, Corbevax, for restricted use in emergency situation.

  • Saturday, 05 February 2022
Vax For Students Important
WATCH: Students Brave Heavy Snowfall To Get Covid-19 Vaccine Jab

WATCH | Students Brave Heavy Snowfall To Get Covid-19 Vaccine Jab

Video Icon
  • Friday, 04 February 2022
Covid vaccination
Over 34 Lakh Eligible Adolescents Given Second Dose Of COVID-19 Vaccine: Govt

With the administration of more than 55 lakh vaccine doses in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 168.47 crore as per provisional reports till 7 am.

  • Friday, 04 February 2022
Review Coverage Of Covid Second Dose Amongst Adolescents Daily: Centre To States, UTs
Review Coverage Of Covid Second Dose Amongst Adolescents Daily: Centre To States, UTs

The vaccination of 15-17 years old started on January 3 and till now 63 per cent have been covered with the first dose in a span of less than a month.

  • Wednesday, 02 February 2022
Unemployment
Nobody Losing Jobs Due To Non-Vaccination, Centre Tells SC

The Centre on Monday refuted the argument by advocate Prashant Bhushan that people are losing their jobs and ration allegedly due to the Covid-19 vaccine mandates issued by various state governments.

  • Monday, 31 January 2022
Cancer Treatment May Inhibit Immune Response To Covid Vaccine
Cancer Treatment May Inhibit Immune Response To Covid Vaccine

While CDK 4/6 inhibitors are not conventionally considered to be as immunosuppressive as chemotherapy, Chumsri found that patients with breast cancer who take these drugs exhibited less optimal neutralising antibody activity.

  • Sunday, 23 January 2022
Sputnik V
Sputnik V Covid Vaccine Shows Higher Omicron-Specific Antibodies Than Pfizer: Study

The study demonstrates that Sputnik V neutralises the Omicron variant by inducing robust antibody response associated with high levels of protection.

  • Friday, 21 January 2022
Vaccination For Under 15 Only After Scientific Data Evolves: Govt
Vaccination For Under 15 Only After Scientific Data Evolves: Govt

Bhushan also said that 52 per cent of children in the 15-18 age group in the country have been vaccinated so far.

  • Friday, 21 January 2022
Sputnik V Shows Strong Protection Against Omicron: Joint Italian-Russian Study
Sputnik V Shows Strong Protection Against Omicron: Joint Italian-Russian Study

Among the top quartile of individuals with high RBD-specific IgG antibodies, 100 per cent of those vaccinated with Sputnik V were able to neutralise Omicron variant in comparison to 83.3 per cent of individuals vaccinated with Pfizer. Among all samples, 74.2 per cent of Sputnik V-vaccinated sera were able to neutralise Omicron vs 56.9 per cent for Pfizer-vaccinated.

  • Thursday, 20 January 2022
Covid vaccine
Covishield, Covaxin Cleared For Regular Market Approval

Hyderabad-based Bharat Biotech had submitted complete information on chemistry, manufacturing, and controls, along with the pre-clinical and clinical data while seeking regular market authorisation for Covaxin.

  • Thursday, 20 January 2022
COVID Vaccine
Total of 158.74 Cr COVID-19 Vaccine Doses Administered; Over 3.7 Cr In 15-18 Age Group Get First Dose

The cumulative COVID-19 vaccine doses administered in the country have reached 158.74 crore so far, the Union Health Ministry said on Tuesday.

  • Tuesday, 18 January 2022
India's First mRNA Covid Vax, All You Need To Know
India's First mRNA Covid Vax, All You Need To Know

mRNA vaccines are considered safe as mRNA is non-infectious, non-integrating in nature, and degraded by standard cellular mechanisms. They are highly efficacious because of their inherent capability of being translated into proteins in the cell.

  • Monday, 17 January 2022
scrollToTop